120 related articles for article (PubMed ID: 11027980)
21. Isolation and transplantation of highly purified autologous peripheral CD34+progenitor cells: purging efficacy, hematopoietic reconstitution following high dose chemotherapy in patients with breast cancer: results of a feasibility study in Japan.
Chou T; Sano M; Ogura M; Morishima Y; Itagaki H; Tokuda Y
Breast Cancer; 2005; 12(3):178-88. PubMed ID: 16110287
[TBL] [Abstract][Full Text] [Related]
22. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma.
Lemoli RM; Cavo M; Fortuna A
J Hematother; 1996 Aug; 5(4):339-49. PubMed ID: 8877709
[TBL] [Abstract][Full Text] [Related]
23. Fate of contaminating t(14; 18)+ lymphoma cells during ex vivo expansion of CD34-selected hematopoietic progenitor cells.
Widmer L; Pichert G; Jost LM; Stahel RA
Blood; 1996 Oct; 88(8):3166-75. PubMed ID: 8874217
[TBL] [Abstract][Full Text] [Related]
24. Autografting with CD34+ peripheral blood stem cells: retained engraftment capability and reduced tumour cell content.
Voso MT; Hohaus S; Moos M; Pförsich M; Cremer FW; Schlenk RF; Martin S; Hegenbart U; Goldschmidt H; Haas R
Br J Haematol; 1999 Feb; 104(2):382-91. PubMed ID: 10050723
[TBL] [Abstract][Full Text] [Related]
25. Isolation and transplantation of highly purified autologous peripheral CD34+ progenitor cells: purging efficacy, hematopoietic reconstitution in non-Hodgkin's lymphoma (NHL): results of Japanese phase II study.
Imai Y; Chou T; Tobinai K; Tanosaki R; Morishima Y; Ogura M; Shimazaki C; Taniwaki M; Hiraoka A; Tanimoto M; Koike T; Kogawa K; Hirai H; Yoshida T; Tamura K; Kishi K; Hotta T;
Bone Marrow Transplant; 2005 Mar; 35(5):479-87. PubMed ID: 15654349
[TBL] [Abstract][Full Text] [Related]
26. Immunocytochemical detection of breast cancer cells in marrow and peripheral blood of patients undergoing high dose chemotherapy with autologous stem cell support.
Franklin WA; Shpall EJ; Archer P; Johnston CS; Garza-Williams S; Hami L; Bitter MA; Bast RC; Jones RB
Breast Cancer Res Treat; 1996; 41(1):1-13. PubMed ID: 8932871
[TBL] [Abstract][Full Text] [Related]
27. Double T cell depletion of bone marrow using sequential positive and negative cell immunoaffinity or CD34+ cell selection followed by Campath-1M; effect on CD34+ cells and progenitor cell recoveries.
Clarke E; Potter MN; Hale G; Waldmann H; Lankester A; Cornish JM; Steward CG; Marks DI; Oakhill A; Pamphilon DH
Bone Marrow Transplant; 1998 Jul; 22(2):117-24. PubMed ID: 9707017
[TBL] [Abstract][Full Text] [Related]
28. Autologous bone marrow transplantation with negative immunomagnetic purging for aggressive B-cell non-Hodgkin's lymphoma in first complete remission.
De Rosa L; Lalle M; Pandolfi A; Ruscio C; Amodeo R
Ann Hematol; 2002 Oct; 81(10):575-81. PubMed ID: 12424539
[TBL] [Abstract][Full Text] [Related]
29. Immunologic purging of autologous peripheral blood stem cell products based on CD34 and CD133 expression can be effectively and safely applied in half of the acute myeloid leukemia patients.
Feller N; van der Pol MA; Waaijman T; Weijers GW; Westra G; Ossenkoppele GJ; Schuurhuis GJ
Clin Cancer Res; 2005 Jul; 11(13):4793-801. PubMed ID: 16000576
[TBL] [Abstract][Full Text] [Related]
30. CD34+ cell positive selection from mobilized peripheral blood by an indirect immunomagnetic method: effect of the type of mobilization and assessment of tumor depletion ability.
Cancelas JA; Querol S; Canals C; Bertran J; Limon A; Amill B; Petriz J; Garcia-Lopez J
J Hematother; 1995 Dec; 4(6):531-8. PubMed ID: 8846013
[TBL] [Abstract][Full Text] [Related]
31. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
Kasow KA; Sims-Poston L; Eldridge P; Hale GA
Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
[TBL] [Abstract][Full Text] [Related]
32. Improvement of tumor cell depletion by combining immunomagnetic positive selection of CD34-positive hematopoietic stem cells and negative selection (purging) of tumor cells.
Hoppe B; Mohr M; Roots-Weiss A; Kienast J; Berdel WE
Bone Marrow Transplant; 1999 Apr; 23(8):809-17. PubMed ID: 10231144
[TBL] [Abstract][Full Text] [Related]
33. Automated CD34+ cell isolation of peripheral blood stem cell apheresis product.
Spohn G; Wiercinska E; Karpova D; Bunos M; Hümmer C; Wingenfeld E; Sorg N; Poppe C; Huppert V; Stuth J; Reck K; Essl M; Seifried E; Bönig H
Cytotherapy; 2015 Oct; 17(10):1465-71. PubMed ID: 25981397
[TBL] [Abstract][Full Text] [Related]
34. CD34 selections from myeloma peripheral blood cell autografts contain residual tumour cells due to impurity, not to CD34+ myeloma cells.
Willems P; Croockewit A; Raymakers R; Holdrinet R; van Der Bosch G; Huys E; Mensink E
Br J Haematol; 1996 Jun; 93(3):613-22. PubMed ID: 8652382
[TBL] [Abstract][Full Text] [Related]
35. Immunomagnetic selection of CD34+ peripheral blood stem cells for autografting in patients with breast cancer.
Hohaus S; Pförsich M; Murea S; Abdallah A; Lin YS; Funk L; Voso MT; Kaul S; Schmid H; Wallwiener D; Haas R
Br J Haematol; 1997 Jun; 97(4):881-8. PubMed ID: 9217192
[TBL] [Abstract][Full Text] [Related]
36. Phase I/II trial of cure-oriented high-dose chemoradiotherapy with transplantation of CD34+ peripheral blood stem cells purified by the immunomagnetic bead method for refractory hematological malignancies. Nagoya CD34+ PBSCT Study Group.
Ogura M; Kagami Y; Suzuki R; Miura K; Uehira K; Kurokawa T; Ito T; Kinoshita T; Emi N; Morishima Y; Kodera Y; Ueda R
Cancer Chemother Pharmacol; 1997; 40 Suppl():S51-7. PubMed ID: 9272135
[TBL] [Abstract][Full Text] [Related]
37. Comparison of T cell depletion strategies from bone marrow, umbilical cord and peripheral blood using five separation systems.
Feugier P; Thévenin S; Billot M; Serrurier B; Loigerot C; Schooneman F; Janot C; Hervé P; Racadot E
Hematol Cell Ther; 1997 Apr; 39(2):67-73. PubMed ID: 9168302
[TBL] [Abstract][Full Text] [Related]
38. Predictive factors for peripheral-blood progenitor-cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization.
Passos-Coelho JL; Braine HG; Davis JM; Huelskamp AM; Schepers KG; Ohly K; Clarke B; Wright SK; Noga SJ; Davidson NE
J Clin Oncol; 1995 Mar; 13(3):705-14. PubMed ID: 7533827
[TBL] [Abstract][Full Text] [Related]
39. Positive selection and transplantation of autologous highly purified CD133(+) stem cells in resistant/relapsed chronic lymphocytic leukemia patients results in rapid hematopoietic reconstitution without an adequate leukemic cell purging.
Isidori A; Motta MR; Tani M; Terragna C; Zinzani P; Curti A; Rizzi S; Taioli S; Giudice V; D'Addio A; Gugliotta G; Conte R; Baccarani M; Lemoli RM
Biol Blood Marrow Transplant; 2007 Oct; 13(10):1224-32. PubMed ID: 17889360
[TBL] [Abstract][Full Text] [Related]
40. Harvest quality and factors affecting collection and engraftment of CD34+ cells in patients with breast cancer scheduled for high-dose chemotherapy and peripheral blood progenitor cell support.
Papadopoulos KP; Ayello J; Tugulea S; Heitjan DF; Williams C; Reiss RF; Vahdat LT; Suciu-Foca N; Antman KH; Hesdorffer CS
J Hematother; 1997 Feb; 6(1):61-8. PubMed ID: 9112219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
